Surgical Science Sweden AB
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.14 USD
11.85 M USD
79.57 M USD
35.49 M
About Surgical Science Sweden AB
Sector
Industry
CEO
Tom Englund
Website
Headquarters
Gothenburg
Founded
1997
IPO date
Jun 19, 2017
Identifiers
2
ISIN SE0014428512
Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, for procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SUSRF is 2.84 USD — it has decreased by −16.72% in the past 24 hours. Watch Surgical Science Sweden AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Surgical Science Sweden AB stocks are traded under the ticker SUSRF.
SUSRF stock has fallen by −16.72% compared to the previous week, the month change is a −16.72% fall, over the last year Surgical Science Sweden AB has showed a −80.41% decrease.
We've gathered analysts' opinions on Surgical Science Sweden AB future price: according to them, SUSRF price has a max estimate of 9.86 USD and a min estimate of 3.03 USD. Watch SUSRF chart and read a more detailed Surgical Science Sweden AB stock forecast: see what analysts think of Surgical Science Sweden AB and suggest that you do with its stocks.
SUSRF reached its all-time high on Nov 18, 2021 with the price of 36.88 USD, and its all-time low was 3.16 USD and was reached on Nov 26, 2025. View more price dynamics on SUSRF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SUSRF stock is 20.07% volatile and has beta coefficient of 0.24. Track Surgical Science Sweden AB stock price on the chart and check out the list of the most volatile stocks — is Surgical Science Sweden AB there?
Today Surgical Science Sweden AB has the market capitalization of 140.77 M, it has decreased by −6.87% over the last week.
Yes, you can track Surgical Science Sweden AB financials in yearly and quarterly reports right on TradingView.
Surgical Science Sweden AB is going to release the next earnings report on Feb 19, 2026. Keep track of upcoming events with our Earnings Calendar.
SUSRF earnings for the last quarter are 0.04 USD per share, whereas the estimation was 0.08 USD resulting in a −41.74% surprise. The estimated earnings for the next quarter are 0.07 USD per share. See more details about Surgical Science Sweden AB earnings.
Surgical Science Sweden AB revenue for the last quarter amounts to 27.96 M USD, despite the estimated figure of 27.51 M USD. In the next quarter, revenue is expected to reach 29.02 M USD.
SUSRF net income for the last quarter is 2.16 M USD, while the quarter before that showed −2.11 M USD of net income which accounts for 202.29% change. Track more Surgical Science Sweden AB financial stats to get the full picture.
No, SUSRF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 274 employees. See our rating of the largest employees — is Surgical Science Sweden AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Surgical Science Sweden AB EBITDA is 22.28 M USD, and current EBITDA margin is 23.74%. See more stats in Surgical Science Sweden AB financial statements.
Like other stocks, SUSRF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Surgical Science Sweden AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Surgical Science Sweden AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Surgical Science Sweden AB stock shows the sell signal. See more of Surgical Science Sweden AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.